Once the expansion project is completed, Labcorp’s Flanders-based site will be capable of producing clinical trial test kits for over 70 countries in Europe, the Middle East and Africa (EMEA). That’s more than twice as many as today! For reference, the Mechelen site served 27 markets in 2021.
“The added capacity supports our customers’ needs for faster, more convenient clinical trial testing and delivery across the EMEA region,” comments Jonathan DiVincenzo, president of the Clinical Trial Testing Solutions group at Labcorp Drug Development. “As we build up our capabilities in Flanders, researchers will experience more flexibility in ordering and turnaround times.”